The immunological properties of cancer have been under investigation since the 1940s, with every indication that the host immune system can have a major influence on the progression of invasive human cancers. Unfortunately, while tumors can be highly antigenic, the human host usually does not appear able to effectively 'reject' them. Moreover, it has been exceedingly difficult to harness the human immune system so as to develop effective 'immunotherapy' for treatment of cancer. A central paradox is that tumor-infiltrating T lymphocytes (TILs) may be either cytotoxic or immunoregulatory. In the latter instance, regulatory T cells within the tumor microenvironment may downregulate or actually abrogate the host immune response, enabling a tumor to more readily escape immune surveillance. A brisk infiltrate of TILs may actually be an unfavorable event, rather than a favorable one. In this issue, Yu and Fu 1 (p. 231) explore the paradox of TILs, by examining the question of whether they are 'friend' or 'foe'. Building upon the concept that it is the type, not the quantity, of tumor-infiltrating cells which influences the prognosis of human cancer, they advance the thesis that immunotherapy for human cancer should seek to increase the function of tumor-infiltrating cytotoxic T lymphocytes, and decrease the function of regulatory T cells. The pathologist examining human cancer tissue may thus have a critical role to play, in that the assessment of the phenotype of tumor-infiltrating lymphocytes will have substantial bearing on selection of appropriate immunotherapy for human cancer. 
Alpha-GalCer takes it to the lung
Sepsis and endotoxic shock constitute a significant clinical challenge and a number of animal models have been produced to dissect the mechanisms involved. Most animal models use lipopolysaccharide (LPS), which causes a systemic inflammation response syndrome consisting of endotoxic shock, disseminated intravascular coagulation, and multiorgan failure, leading to rapid death in most mouse strains. LPS-induced endotoxic shock is entirely dependent on the TNFa/TNFRI effector pathway. It has also been shown in multiple models that INFg aggravates septic shock, at least partly by increasing TNFa production. There is controversy over the critical source of INFg. In separate observations, both NK and NKT INFg-producing cells have been shown to play a role in LPS-mediated endotoxic shock. In this issue, Ito et al 1 (p. 254) clearly show that exposure to alpha-galactosylceramide (AlphaGalCer), a marine sponge glycolipid that serves as a ligand for Va14 NKT cells, dramatically enhances the severity of LPS-mediated endotoxic shock. They also show that this sensitization is dependent on the presence of Va14 NKT cells, INFg and TNFa. Less expectedly, however, Alpha-GalCer sensitization changed the pathological manifestations of LPStreated mice. Most models are dominated by fulminant hepatic apoptosis and hemorrhages, but Alpha-GalCer sensitization redirects the immunopathogenesis from the liver to the lung with widespread pulmonary infiltrates of inflammatory cells and massive apoptosis. This has an important clinical significance because respiratory failure is a consistent feature in severely septic patients. This Alpha-GalCer sensitization model thus provides a novel tool to unravel the mechanism by which NKT cells mobilization shifts the pathology of sepsis from the liver to the lung, and constitutes a uniquely clinically relevant model for interventions on the respiratory system as a target of septic shock. 
Clinical diagnosis of genetic polymorphisms using multiplex PCR
Genetic single-nucleotide polymorphisms (SNPs) are the focus of intense study, as they may play a key role in determining individual susceptibilities to multigenetic inherited conditions such as diabetes, cardiovascular diseases, or cancer. In addition, point mutations clearly underlie specific inherited disorders. Hence, assessment of SNPs in the human genome has become a major objective of human research. High-throughput parallel genotyping of large numbers of single-nucleotide variations is required in order to avoid the expensive and timeconsuming process of direct sequencing, and multiple genotyping methodologies have been developed.
Arrays of oligonucleotides (DNA chips) on solid support systems provide opportunity to hybridize thousands of oligonucleotide sequences simultaneously. Unfortunately, the annealing affinities of variable probe-target heteroduplexes may not be identical, so that assessment of multiple related sequences in a single hybridization experiment may be suboptimal for simultaneous discrimination of sequence variants. An alternative approach is minisequencing on the chip, using solid-phase immobilized extension primers. This requires liquid-phase enzymatic reactions followed by detection steps to capture the extension products. 
